CARE Ratings Limited (CARERATING.NS)

INR 1373.6

(-1.06%)

EBITDA Summary of CARE Ratings Limited

CARE Ratings Limited's latest annual EBITDA in 2023 was 1.12 Billion INR , down -21.58% from previous year.
CARE Ratings Limited's latest quarterly EBITDA in 2024 Q2 was 675.79 Million INR , up 100.57% from previous quarter.
CARE Ratings Limited reported an annual EBITDA of 1.37 Billion INR in 2022, up 33.88% from previous year.
CARE Ratings Limited reported an annual EBITDA of 1.06 Billion INR in 2021, down -9.97% from previous year.
CARE Ratings Limited reported a quarterly EBITDA of 218.22 Million INR for 2024 Q1, up 16.05% from previous quarter.
CARE Ratings Limited reported a quarterly EBITDA of 290.33 Million INR for 2023 Q4, down -21.61% from previous quarter.

Annual EBITDA Chart of CARE Ratings Limited (2023 - 2011)

Historical Annual EBITDA of CARE Ratings Limited (2023 - 2011)

Year	EBITDA	EBITDA Growth
2023	1.12 Billion INR	-21.58%
2022	1.37 Billion INR	33.88%
2021	1.06 Billion INR	-9.97%
2020	1.27 Billion INR	21.32%
2019	1.12 Billion INR	-39.83%
2018	1.62 Billion INR	-29.57%
2017	2.11 Billion INR	39.79%
2016	2.06 Billion INR	-8.69%
2015	1.74 Billion INR	6.12%
2014	2.03 Billion INR	26.96%
2013	1.83 Billion INR	9.15%
2012	1.35 Billion INR	11.83%
2011	1.23 Billion INR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	675.79 Million INR	100.57%
2024 Q1	218.22 Million INR	16.05%
2023 Q4	290.33 Million INR	-21.61%
2023 Q2	530.98 Million INR	80.81%
2023 Q1	293.67 Million INR	-25.48%
2023 FY	- INR	-21.58%
2023 Q3	370.37 Million INR	-30.25%
2022 Q1	236.53 Million INR	-20.22%
2022 Q4	394.08 Million INR	33.75%
2022 Q3	294.63 Million INR	-41.61%
2022 Q2	504.59 Million INR	113.32%
2022 FY	- INR	33.88%
2021 Q2	394.31 Million INR	147.09%
2021 Q3	217.61 Million INR	-44.81%
2021 Q4	296.48 Million INR	36.24%
2021 FY	- INR	-9.97%
2021 Q1	159.58 Million INR	-42.15%
2020 Q1	145.6 Million INR	92.07%
2020 Q2	499.1 Million INR	242.78%
2020 Q4	275.86 Million INR	4.57%
2020 FY	- INR	21.32%
2020 Q3	263.8 Million INR	-47.14%
2019 Q4	75.8 Million INR	-69.34%
2019 Q2	455.46 Million INR	128.61%
2019 Q1	199.23 Million INR	-46.11%
2019 FY	- INR	-39.83%
2019 Q3	247.24 Million INR	-45.72%
2018 Q1	280.29 Million INR	-64.85%
2018 FY	- INR	-29.57%
2018 Q4	369.68 Million INR	1.93%
2018 Q2	612.24 Million INR	118.43%
2018 Q3	362.68 Million INR	-40.76%
2017 Q4	797.44 Million INR	71.55%
2017 Q1	385.7 Million INR	0.0%
2017 Q2	659.06 Million INR	70.88%
2017 Q3	464.86 Million INR	-29.47%
2017 FY	- INR	39.79%
2016 FY	- INR	-8.69%
2015 FY	- INR	6.12%
2014 FY	- INR	26.96%
2013 FY	- INR	9.15%
2012 Q4	376.57 Million INR	-0.42%
2012 Q3	378.17 Million INR	28.13%
2012 FY	- INR	11.83%
2012 Q2	295.15 Million INR	0.0%
2011 FY	- INR	0.0%

Peer EBITDA Comparison of CARE Ratings Limited

Name	EBITDA	EBITDA Difference
BSE Limited	6.22 Billion INR	81.99%
CRISIL Limited	9.75 Billion INR	88.501%
ICRA Limited	2.23 Billion INR	49.88%
Multi Commodity Exchange of India Limited	1.39 Billion INR	19.732%